The purpose of this study is to compare the use of the Glycotest HCC Panel vs. the serum protein biomarker alpha-fetoprotein (AFP) for the early detection of Hepatocellular Carcinoma (HCC).

A significant difference in serum alpha-fetoprotein (AFP)-production was observed in HCC's associated with underlying HBV as opposed to those associated with HCV (Table 1). The median level of ...

Hepatoid adenocarcinoma (HAC) is a rare tumour that produces an alpha-fetoprotein (AFP) mimicking hepatocellular carcinoma (HCC). Adrenal HAC is exceedingly rare. Here we report extremely high ...

diagnosed with a hepatocellular carcinoma (HCC) with 40 mm (α-fetoprotein (AFP) 205 ng/mL). He underwent segmental liver resection and pathology analysis was consistent with HCC and cirrhosis in the ...

which bears the greatest HCC burden worldwide. In patients exceeding the Milan criteria but fulfilling the Hangzhou criteria, we further stratified subgroups to help select the optimal candidates. We ...

Early detection of hepatocellular carcinoma (HCC) is crucial for improving survival in patients with chronic hepatitis. The ...

Adding AFP L-3 or DCP did not change the predictive ability of the P9 model. Conclusions We identified a panel of nine serum biomarkers that is independently associated with developing HCC in ...

Among the analyzed factors including sex, age, tumor size, cause of cirrhosis, AFP, PIVKA, differentiation, Child-Pugh class, death from HCC, recurrence, portal vein thrombus, tumor number, modality ...

were more likely to develop HCC at a younger age than patients with hepatitis C (HCV) (HBV-26% under age 40, HCV-0% under age 40; p < 0.001), with greater serum alpha-Fetoprotein production ...